SARS-CoV-2 Neutralizing Antibody Rapid Test

Biotime SARS-CoV-2 Neutralizing Antibody rapid test is a fluorescence immunoassay(FIA) for the qualitative detection of total neutralizing antibodies to SARS-CoV-2 in human serum or plasma. It is useful as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.

SARS-CoV-2 IgG/IgM Rapid Qualitative Test

The Biotime SARS-CoV-2 IgG/IgM Rapid Qualitative Test is intended to qualify the SARS-CoV-2 IgG and IgM antibody in human plasma, serum or whole blood by colloidal gold immunochromatography assay. The test can be used as an aid detection to SARS-CoV-2 infection and thus caused COVID-19 disease.

SARS-CoV-2 Antigen Rapid Qualitative Test

The SARS-CoV-2 Antigen Rapid Qualitative Test is a colloidal gold immunochromatography intended for the qualitative detection of nucleocapsid antigens from SARS-CoV-2 in human nasal swabs, throat swabs, and sputum from individuals who are suspected of COVID-19 by their healthcare provider. within the first five days of the onset of symptoms.

5 in 1 (cTnI/ CK-MB/ Myo/ NT-proBNP/ D-Dimer) Rapid Quantitative Test

Cardiac markers are used in the diagnosis and risk stratification of patients with chest pain, suspected Acute Coronary Syndrome(ACS) and Heart Failure(HF), etc.

PCT Rapid Quantitative Test (Chemiluminescence Immunoassay)

PCT Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Procalcitonin concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of inflammation diseases.

Lp-PLA2 Rapid Quantitative Test(Chemiluminescence Immunoassay)

Lp-PLA2 Rapid Quantitative Test(Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the lipoprotein-associated phospholipase A2 (Lp-PLA2) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.

FLI-100 FIA Analyzer

The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.

Dengue NS1 Antigen Rapid Test

The Dengue NS1 Antigen Rapid Test is a lateral flow immunoassay for the qualitative detection of Dengue virus NS1 antigen in human serum, plasma or whole blood. It is intended to be used by professionals as a screening test and provides a preliminary test result to aid in the diagnosis of infection with the dengue virus. For professional in vitro diagnostic use only.

cTnI Rapid Quantitative Test

cTnI is a myocardial marker with high specificity and good sensitivity. The Biotime cTnI test kit has a wide detection range and high accuracy.

Product Name	SARS-COV-2 Neutralizing Antibody Rapid Test
Sample Type	Serum/Plasma
Loading Volume	80 uL
Reaction Time	10 min
Interpretation of Results	Negative: <1.5 IU/ml；Positive: ≥1.5 IU/ml
Shelf Life	24 months
Storage Condition	2-30℃
Unit	25 kits/box

Solutions

Covid-19 Solution

SARS-CoV-2 Neutralizing Antibody Rapid Test